SCHEMBL2460331

SCHEMBL2460331

C(=Cc1ccno1)c1ccc[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.39
MAPT P10636 5/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 3/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 1/20 0.33
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32
HTT P42858 2/20 0.31
NPC1 O15118 1/20 0.31
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
GAA P10253 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2460330 1.00 CHEK1 (0.39) CHEK1MAPTSMN1; SMN2MAPK1RAB9A
SCHEMBL2464131 0.76 MAPT (0.52) CHEK1MAPTSMN1; SMN2MAPK1RAB9A
SCHEMBL2464133 0.76 MAPT (0.52) CHEK1MAPTSMN1; SMN2MAPK1RAB9A
SCHEMBL2463819 0.74 AOC1 (0.43) MAPTSMN1; SMN2MEN1TSHRKMT2A
SCHEMBL2463818 0.74 AOC1 (0.43) MAPTSMN1; SMN2MEN1TSHRKMT2A
SCHEMBL2465535 0.71 NPC1 (0.44) RAB9ANPC1
SCHEMBL2465536 0.71 NPC1 (0.44) RAB9ANPC1
SCHEMBL2455995 0.70 HCAR2 (0.43) MAPTSMN1; SMN2RAB9AL3MBTL1ALDH1A1
SCHEMBL2455993 0.70 HCAR2 (0.43) MAPTSMN1; SMN2RAB9AL3MBTL1ALDH1A1
SCHEMBL2458444 0.69 CYP2A6 (0.47) MAPTMAPK1GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-09-29 US disclosed
WO-2010068287-A2 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY ANGION BIOMEDICA CORP. (US) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY HGF, HDGF, MET CHEK1 2771/4885MAPT 3790/4885SMN1; SMN2 3462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.